https://www.selleckchem.com/products/ON-01910.html
Herein we report the design, synthesis and assessment of the first example of a squaramide-based self-immolative system triggered by an enzymatic reduction. We have proved that the release of the alkylating agent N',N'-(bis(2-chloroethyl)benzene)-1,4-diamine (ANM) provokes a dramatic reduction of the survival factor in glioblastoma cells, evidencing the suitability of the squaramide-based spacer for drug delivery applications.We study the effects of osmotic shocks on lipid vesicles via coarse-grained molecular dynamics simulations by e
Like
Comment
Share
